Publications by authors named "Bernhard Leibl"

This study aimed to evaluate the benefit of additional administration of oxaliplatin during fluorouracil-based neoadjuvant radiochemotherapy (nRCT) in terms of pathologic complete remission (pCR), disease-free survival (DFS), and overall survival (OS) in patients with advanced rectal cancer. Between 2006 and 2021, 669 patients (pts) were diagnosed with locally advanced rectal cancer, of whom a total of 414 pts with nRCT were identified and included in the study. A total of 283 pts were treated by nRCT using concurrent chemotherapy with fluorouracil or capecitabine; 131 pts were treated using a combination of fluorouracil or capecitabine and oxaliplatin.

View Article and Find Full Text PDF
Article Synopsis
  • - This study aimed to assess the long-term outcomes of patients with advanced adenocarcinoma of the esophagus who underwent neoadjuvant chemoradiation followed by radical surgery between 2005 and 2015.
  • - Out of 102 patients analyzed, 51 received the full treatment protocol, which included a chemotherapy regimen and surgical resection, resulting in 5-year overall and disease-free survival rates of 40% and 32%, respectively.
  • - Key factors impacting survival included age, tumor response, and the occurrence of distant metastases, with a median survival time of about 45 months for the treated group and a high rate of clear surgical margins achieved post-operation.
View Article and Find Full Text PDF

Purpose: To retrospectively evaluate treatment results and toxicity following a combined approach consisting of neoadjuvant radiochemotherapy and radical surgery in advanced adenocarcinoma of the esophagus and gastroesophageal junction.

Patients And Methods: Between 2005 and 2009, a total of 41 consecutive patients with newly diagnosed nonmetastatic adeno-carcinoma of the esophagus and the esophagogastric junction were evaluated, of whom 23 received neoadjuvant radiochemo-therapy (RCT). A total dose of 50.

View Article and Find Full Text PDF

Background And Aim: Several studies have claimed that mesh repair of incisional hernia lowers recurrence rates when compared to suture repair. We investigated the relative effectiveness of mesh and suture repair in a large homogeneous cohort of patients with primary incisional hernia.

Patients And Methods: In a retrospective single-centre cohort study, a total of 446 consecutive patients were identified, of whom 86% could be followed up.

View Article and Find Full Text PDF

It is unknown at present what the best method is among mesh implantation, central incision, reconstructing the deep inguinal ring, or a non-incised mesh implant in laparoscopic hernia surgery. Further, it is unproven to what extent a circular enclosure of the cremasteric structures by an incised mesh implant could cause postoperative complications and complaints. To evaluate the possible effects of different configurations and fixation techniques of mesh implants in transperitoneal repair of inguinal hernias, a randomized trial (phase IIIa study) was conducted to compare incised versus non-incised mesh and clip fixation versus suturing the mesh.

View Article and Find Full Text PDF

Patients with International Union Against Cancer (UICC) stage IIb and III colon cancer and stage II and III rectal cancer may receive adjuvant chemotherapy with 5-fluorouracil (5-FU). High levels of thymidylate synthase (TS) and dihydropyrimidine dehydrogenase (DPD) have been associated with resistance to 5-FU in advanced colorectal cancer. The aim of this study was to investigate the association of TS and DPD mRNA levels with recurrence-free survival in patients with colorectal cancer who are receiving adjuvant 5-FU-based chemotherapy.

View Article and Find Full Text PDF